Introduction:
Guided bone regeneration (GBR) is a critical technique in implant dentistry, facilitating the successful integration of dental implants by promoting bone growth in areas with deficiencies. However, the success of GBR is influenced by several patient-related risk factors that can significantly impede the healing process and the overall outcome of dental implants. Understanding and addressing these risk factors is essential for dental professionals to optimize treatment protocols and enhance patient outcomes. This article explores the primary risk factors that can affect the efficacy of GBR, including systemic health conditions like osteonecrosis of the jaw (ONJ) and diabetes, as well as lifestyle factors such as chronic smoking.
How Can GBR Promote Dental Implant Success?
Guided bone regeneration (GBR) is an essential concept in modern implant dentistry, playing a crucial role in the effective osseointegration or bone-implant fusion of dental implants. This technique significantly enhances dental implants' success rates, functionality, and aesthetics, especially in rehabilitating edentulous patients.
Research studies have extensively examined the efficacy of GBR, establishing it as a reliable method for both horizontal and vertical bone augmentation in cases requiring dental implants. While dental implants are considered the gold standard for prosthetic rehabilitation of missing teeth, they have specific inclusion criteria. Not all patients, particularly those with systemic diseases, immunocompromised conditions, poor oral hygiene, or a history of moderate to severe gingival or periodontal diseases, are ideal candidates for dental implants. In such cases, the risk of implant failure can be high, even in the short term.
What Are the Materials Used in GBR?
For cases deemed suitable for dental implantation to rehabilitate the edentulous jaw, guided bone regeneration (GBR) emerges as a cutting-edge technique to prevent postoperative complications. The primary rationale behind GBR is to encourage the growth of desirable osteogenic (bone-forming) cells into the bone defect while inhibiting the infiltration of undesirable connective tissue cells. Over the past two decades, the biological efficacy of GBR in regenerating bone and facilitating successful bone augmentation has revolutionized the management of oral and maxillofacial defects. Implant dentists and maxillofacial surgeons prefer GBR for addressing osseous defects, making it a cornerstone in modern dental implantology.
GBR involves the use of various materials to promote bone regrowth in edentulous areas and support osseointegration for dental implants. These materials include:
-
Expanded or high-density PTFE (Polytetrafluoroethylene) membranes.
-
Titanium-reinforced PTFE membranes.
-
Resorbable collagen membranes.
-
Titanium meshes or plates for bone regeneration.
-
Synthetic polymer materials like PDLLA (Poly D, L lactide) devices.
These components play a critical role in ensuring the success of GBR by creating a conducive environment for bone regeneration and implant stability.
What Are the Complications in GBR Procedure?
The success of guided bone regeneration (GBR) largely depends on the extent of the osseous defects, which can pose significant surgical challenges for implant dentists, particularly when placing implants in regions with low-density or low-quality bone. Additionally, several other factors must be considered to promote the success of GBR materials. Strict and rigorous surgical guidelines and protocols have been established for maxillofacial surgeons and implant dentists to optimize the outcomes of GBR. For the functional, prosthetic, and aesthetic success of dental implants, it is crucial to consider the health conditions and systemic factors that may lead to potential GBR failure.
Here are three major causes of GBR failure due to complications from these conditions:
-
Smoking: According to research in implant dentistry, smoking tobacco is a major factor that can cause soft tissue complications and negatively impact oral wound healing. Smoking inhibits the growth of healthy osteoblasts or osteogenic cells in osseous defects, which is crucial for the success of guided bone regeneration (GBR).
Implant dentists should strongly advise patients to refrain from smoking during the course of GBR treatment. Smoking not only impairs the production of fibroblast cells but also releases toxic compounds known as tobacco-specific nitrosamines (TSNAs) in the oral cavity. This results in a significant breach in oral immunity, with 80 to 90 percent of smokers having dental implants at an increased risk of prosthetic failure and postoperative complications, such as soft tissue-related peri-implantitis.
-
MRONJ /Medically Related Osteonecrosis of the Jaw: Patients who are commonly prescribed anti-resorptive drugs or treatments face significant challenges in bone metabolism, which can interfere with the bone-implant fusion process necessary for successful dental implant treatment. The integration or fusion of the dental implant with the underlying jawbone is crucial, and these systemic medications can hinder this process. In cases of osseous diseases, intraosseous cancers, malignancies, or metastases, guided bone regeneration (GBR) is entirely contraindicated. Attempting GBR in such scenarios can lead to complete failure of both the bone augmentation procedure and the dental implantation. Patients with these conditions are often prescribed bisphosphonates or other anti-resorptive drugs, which reduce bone and soft tissue turnover and further compromise the vascularity of the oral cavity. This is why individuals with osteoporosis, bone diseases, or osteonecrosis of the jaw (such as medication-related osteonecrosis of the jaw, MRONJ) are generally contraindicated for dental implants. The risk of GBR and dental implant failure is significantly higher in these patients.
-
Diabetes: Oral wound healing is severely compromised in patients with advanced diabetes. Even in individuals with controlled diabetes or blood sugar levels, the long-term success rates of guided bone regeneration (GBR) remain debatable. While diabetes is not an absolute contraindication for GBR, irregular blood sugar spikes and prolonged hypoxia or insufficient perfusion can lead to inadequate growth of osteogenic cells in bone defects, increasing the risk of procedure failure. Implant dentists should collaborate closely with the patient's physician or diabetologist to ensure optimal glycemic control. Current protocols recommend that the glycosylated hemoglobin (HbA1c) level for dental implant candidates with diabetes should be less than 7 percent to improve the chances of GBR success and minimize complications.
Conclusion:
In conclusion, three major risk factors can significantly impede the success of guided bone regeneration (GBR): systemic health conditions such as osteonecrosis of the jaw (ONJ) and diabetes, as well as chronic smoking. Patients on anti-resorptive drugs face reduced bone and soft tissue turnover, compromising oral vascularity and increasing the risk of GBR failure. In diabetic patients, irregular blood sugar levels and prolonged hypoxia can hinder osteogenic cell growth, necessitating close collaboration with physicians to maintain HbA1c levels below seven percent for improved outcomes. Chronic smoking inhibits osteoblast growth, releases toxic compounds, and impairs fibroblast production, leading to a high risk of prosthetic failure and postoperative complications like peri-implantitis. Thorough patient evaluation and interdisciplinary collaboration are essential for addressing these risk factors, ensuring optimal patient health, and enhancing the chances of successful bone augmentation and dental implant outcomes.
